Aurobindo Pharma holds firm as momentum cools

closed at ₹1,706.90 after recovering from an intraday low of ₹1,681. The candle reflects demand on dips and keeps the broader rising sequence intact. Since March, price has consistently made higher peaks and higher troughs, and the stock remains above both of its key moving averages. This is a different setup from a breakdown: the trend is positive, but it is now pausing near a recent high. The 20-day average at ₹1,684 is the first dynamic support, while the rising 55-day average near ₹1,642 provides a stronger base. MACD is below its signal line and the histogram is negative, so upside momentum has cooled even though price has not yet broken the trend. That calls for patience rather than chasing strength near the top of the range. ₹1,684 is the first level to defend; below that, ₹1,642 becomes important. A move above ₹1,715–₹1,730 can revive the advance and put the recent high zone back in focus. US generics performance, product approvals and currency movement remain key drivers for the pharma business.